PL4527373T3 - Nowe preparaty amisulprydu - Google Patents

Nowe preparaty amisulprydu

Info

Publication number
PL4527373T3
PL4527373T3 PL24206976.3T PL24206976T PL4527373T3 PL 4527373 T3 PL4527373 T3 PL 4527373T3 PL 24206976 T PL24206976 T PL 24206976T PL 4527373 T3 PL4527373 T3 PL 4527373T3
Authority
PL
Poland
Prior art keywords
amisulpride
new formulations
formulations
new
Prior art date
Application number
PL24206976.3T
Other languages
English (en)
Inventor
Massimo Baldacci
Original Assignee
Laboratori Baldacci S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratori Baldacci S.P.A. filed Critical Laboratori Baldacci S.P.A.
Publication of PL4527373T3 publication Critical patent/PL4527373T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL24206976.3T 2019-07-31 2020-07-30 Nowe preparaty amisulprydu PL4527373T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102019000013524A IT201900013524A1 (it) 2019-07-31 2019-07-31 Nuove formulazioni di amisulpride

Publications (1)

Publication Number Publication Date
PL4527373T3 true PL4527373T3 (pl) 2025-12-01

Family

ID=69105952

Family Applications (2)

Application Number Title Priority Date Filing Date
PL24206976.3T PL4527373T3 (pl) 2019-07-31 2020-07-30 Nowe preparaty amisulprydu
PL20764447.7T PL4003297T3 (pl) 2019-07-31 2020-07-30 Nowe preparaty amisulprydu

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL20764447.7T PL4003297T3 (pl) 2019-07-31 2020-07-30 Nowe preparaty amisulprydu

Country Status (9)

Country Link
EP (2) EP4003297B1 (pl)
BR (1) BR112021025616A2 (pl)
ES (2) ES3014539T3 (pl)
HU (1) HUE070449T2 (pl)
IT (1) IT201900013524A1 (pl)
LT (2) LT4003297T (pl)
PL (2) PL4527373T3 (pl)
PT (2) PT4003297T (pl)
WO (1) WO2021019479A2 (pl)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201702250D0 (en) * 2017-02-10 2017-03-29 Acacia Pharma Ltd Method

Also Published As

Publication number Publication date
WO2021019479A3 (en) 2021-03-11
ES3057288T3 (en) 2026-02-27
LT4003297T (lt) 2025-03-10
PL4003297T3 (pl) 2025-04-07
LT4527373T (lt) 2026-01-12
HUE070449T2 (hu) 2025-06-28
ES3014539T3 (en) 2025-04-23
PT4527373T (pt) 2025-12-23
EP4527373B1 (en) 2025-09-24
WO2021019479A2 (en) 2021-02-04
BR112021025616A2 (pt) 2022-02-08
EP4003297B1 (en) 2024-11-20
EP4527373A1 (en) 2025-03-26
PT4003297T (pt) 2025-02-21
IT201900013524A1 (it) 2021-01-31
EP4003297A2 (en) 2022-06-01

Similar Documents

Publication Publication Date Title
GB2586940B (en) Therapeutic compositions
EP4125815A4 (en) THERAPEUTIC COMPOSITIONS
EP3886820B8 (en) Capsule formulations
IL287224A (en) New formulations containing melphalan
GB201915094D0 (en) New formulations
IL290356A (en) Formulations for Resotide
IL292682A (en) Formulation of x842 for oral administration
EP4007590A4 (en) FORMULATIONS INCLUDING DIHYDROHONOKIOL
GB202117828D0 (en) New formulations
GB201904338D0 (en) Fluorouracil-containing formulations
IL284691A (en) formulations
ZA202105399B (en) Use of spiropidion
EP3873446A4 (en) THERAPEUTIC COMPOUNDS AND COMPOSITIONS
IL283593A (en) Bernaflam oral preparations
LT4527373T (lt) Naujos amisulprido formos
GB201910092D0 (en) New formulations
PT3943070T (pt) Formulações de ação prolongada de bedaquilina
GB201910093D0 (en) New formulations
HK40052508A (en) Oral formulations of branaplam
GB201911063D0 (en) Formulations
HK40060891B (en) Therapeutic compositions
GB201905105D0 (en) Formulations
HK40042383B (en) Therapeutic compositions
HK40042383A (en) Therapeutic compositions
HK40067829A (en) Novel formulations comprising melflufen